
Viscosupplementation is a medical procedure in which injections of hyaluronic acid are given to supplement the viscosity (thickness) of the fluid in the knee. It is used to treat knee pain caused by osteoarthritis. Viscosupplementation injections aim to lubricate and cushion the cartilage inside the knee where osteoarthritis has worn away cartilage cushioning. The need for viscosupplementation is rising in the US due to a growing geriatric population prone to osteoarthritis, along with the advantages of intra-articular injections which provides relief from knee pain for 6-12 months.
The United States of America Viscosupplementation Market is estimated to be valued at USD 1.54 Bn in 2024 and is expected to reach USD 2.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.
Key players operating in the United States of America Viscosupplementation are Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Sanofi S.A., Anika Therapeutics Inc. Johnson & Johnson dominates the US viscosupplementation market with its popular brands called Durolane and Monovisc. F. Hoffmann-La Roche AG offers hyalgan and supartz injections.
The key opportunities in the United States of America Viscosupplementation Market include a rapidly aging population, growing incidence of obesity leading to knee issues and multi-dose vial launches. The market is witnessing expansion in the number of doses per vial to reduce cost per injection and drive compliance. Global expansion is another important factor in the US viscosupplementation industry. Key companies are expanding internationally through acquisitions and new product launches. For instance, Anika Therapeutics acquired Arthrosurface and licenses its orthobiologics portfolio globally.
Market drivers
Rising geriatric population prone to osteoarthritis is a major market driver. Over 60 million Americans are aged 65 or older and this number is projected to double by 2060. Growing incidence of obesity and related knee issues such as arthritis among Americans aged 30-64 is another driver. Obesity rates have risen from 30% to over 40% in the past two decades.
Market restrain
Reimbursement issues pose a challenge as not all insurance payers provide coverage for viscosupplementation injections consistently. High prices of multi-dose vials also restrict market potential to some extent. The costs range from $600 to $900 per injection.
Segment Analysis
The United States of America viscosupplementation market is dominated by single injection viscosupplementation sub segment. Single injection viscosupplementation holds more than 60% of the total market share as it offers long lasting relief from pain for around 6 months with single injection as compared to other options requiring multiple injections. This reduces burden on patients of frequent hospital visits for injections. The market is further segmented based on application as knee, hip and other joints. The knee viscosupplementation sub segment dominates with around 80% share due to rising incidence of knee osteoarthritis in the country. Knee osteoarthritis is becoming common due to obesity, sedentary lifestyle and aging population profile.
Global Analysis
North America region dominates the global viscosupplementation market with United States being the largest market. The region accounts for more than 70% of the total viscosupplementation procedure volume globally due to rising prevalence of lifestyle diseases like obesity leading to orthopedic issues. Moreover, availability of favorable reimbursement policies and growing awareness about new treatment options is supporting market growth. Asia Pacific is fastest growing region owing to improving healthcare infrastructure and increasing medical tourism in countries like India and China.
Get this Report in Japanese Language: アメリカ合衆国の粘性補充市場
Get this Report in Korean Language: 미국 점액 보충 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)